Skip to main content

HPS Network attends the American Thoracic Society meeting

Recently the Hermansky-Pudlak Sydrome Network attended the international meeting of the American Thoracic Society. It is one of the biggest medical events we attend all year. There were approximately 14,000 lung doctors and researchers gathered together in one place. If you want to read more about the meeting, I suggest visiting www.hpsnetwork.org. We will be posting the news stories there.

But here is the place for me to share a few personal reflections.

Even though the vast majority of the attendees are not working on Hermansky-Pudlak Syndrome, it was still very comforting to me to see so much research being done on lungs. There’s a saying, the rising tide raises all boats. Better understanding of the lungs, and lots of different lung diseases, could someday yield a clue, or a technique, that might benefit patients with HPS. For example, I know that some of the Cystic Fibrosis researchers are working on a way to deliver gene therapy to the lungs. While our therapy might be different, our doctors might be able to use the same delivery system.

We were very excited to have several doctors from Puerto Rico drop by the booth. We hope to stay in touch with them.
 
And, of course, we were thrilled to see our own researchers and doctors come by. This year I wasn’t able to make it to the poster sessions. I know there were some on HPS. I’m sad I didn’t get to see them or take pictures.. But, one can’t be everywhere.

We also tried something new this year. We held an HPS Doctor’s Dinner. It was a great investment. It fosters friendship and collaboration among those doctors and researchers interested in HPS. I think it is something, funding allowing, we will continue to do.

Perhaps best of all we had a record crowd. The Nieves and Rodriguez families (minus the kids) both came to the Breathing Better event and helped us set up the booth in the exhibit hall. The Nieves came back the next day to help us at the booth. The rest of the HPS team were Angie, Carmen and me in one hotel room, and Ashley and Donna in the other room.


Comments

Popular posts from this blog

Ratner's Cheesecake

Here's another recipe from Toby! Thanks Toby......and I'll get the others posted soon! Ratner's Cheesecake and plain cookies Ratner's was a Jewish dairy restaurant in the lower East Side of Manhattan. This recipe, from my disintegrating, no longer in print Ratner's cookbook, is the closest I've ever gotten to reproducing the rich, heavy cheesecake my mother made when I was a kid. It's worth the time it takes to prepare and every last calorie. Dough Can be prepared in advance. Makes enough for two cakes. Can be frozen or used to make cookies – see recipe below. 1 cup sugar 1 teaspoon vanilla extract 1 cup shortening 1 teaspoon lemon extract 1 cup butter 2 eggs 3 cups sifted cake flour ½ teaspoon salt 2 cups all purpose flour 1 teaspoon baking powder 1. In a bowl, combine all ingredients with hands. Refrigerate 3 -4 hours, or preferably overnight. Filling (for

The next generation with Hermansky-Pudlak Syndrome

I'm so behind on posting about the trip to Puerto Rico. Since the episode of Mystery Diagnosis on Hermansky-Pudlak Syndrome ran right after we got home, it's been a little busy. These, however, are my favorite pictures from Puerto Rico. I know, not pretty senery etc - but these little guys and gals inspire me. They are the next generation of folks with HPS, and if we keep up the hard work, they will live better lives because of it. They motivate me.

Some good news about Pirfenidone

Below is a press release from Intermune, the company that makes Pirfenidone. They have essentially reviewed the various clinical trials going on, and decided that Pirfenidone is safe and well tolerated. That would pretty much go along with what we've observed in the HPS community as well. We have a few folks that have been on the drug since the late 90s and continue to do well. Of course, as a journalist, I do have to say consider the source - but at the same time, as someone in a Pirfenidone trial, it's good to know. Results of Comprehensive Safety Analysis of pirfenidone In IPF Patients Presented At European Respiratory Meeting - Analysis shows safety and tolerability of pirfenidone across four clinical trials - VIENNA, Sept. 14 /PRNewswire-FirstCall/ -- InterMune, Inc. (Nasdaq: ITMN ) today announced that the results of a comprehensive review of safety data from four clinical studies were presented at the 2009 European Respiratory Society Annual Congress in Vienna, Austria